marketing agreement

NEW YORK (GenomeWeb) – Cancer Genetics today said that it has signed a multi-year agreement with PathAdvantage Associated to offer its FHACT test, a FISH-based genomic test for detecting and managing cervical cancer, and to collaborate on research in support of the test.

NEW YORK (GenomeWeb) – Appistry said today that it has signed a deal to include Personal Genome Diagnostics' CancerSelect panel in the recently released Appistry CloudDx genomics testing service.

NEW YORK (GenomeWeb) – Veracyte today said that it has signed a partnership with Fleury Medicine and Health to make its Afirma Gene Expression Classifier for thyroid cancer diagnosis available to patients in Brazil.

NEW YORK (GenomeWeb) – Biometric solutions firm Morpho will market IntegenX's RapidHit DNA analysis system to law enforcement and government agencies in certain countries as part of a deal announced today.

NEW YORK (GenomeWeb News) – Medison will make available CardioDx's Corus CAD diagnostic test for obstructive coronary artery disease in Israel as part of an agreement announced today.

NEW YORK (GenomeWeb News) – BioDiscovery and N-of-One today announced a marketing agreement to provide genomic analysis interpretation solutions.

NEW YORK (GenomeWeb News) – Good Start Genetics today announced a deal with PerkinElmer to expand access to the GoodStart Select menu of genetic carrier screening tests.

NEW YORK (GenomeWeb News) – Personalized medicine firm Transgenomic today announced that it has signed a deal under which PerkinElmer will market and distribute its portfolio of molecular diagnostic oncology products in all markets outside the US.

NEW YORK (GenomeWeb News) – Metabolon and Bostwick Laboratories today announced an exclusive marketing agreement covering Metabolon's Prostarix test for stratifying prostate cancer risk.

NEW YORK (GenomeWeb News) – Enzo Biochem today said that it has signed an agreement to market Sequenom's MaterniT21 Plus test service in the northeast US.